Skip to content

Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders

Real-time fMRI Neurofeedback as a Treatment Tool for Alcohol Dependence - Protocol Optimisation Phase

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02406456
Enrollment
15
Registered
2015-04-02
Start date
2015-03-31
Completion date
2015-08-31
Last updated
2015-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse

Brief summary

Participants will undergo a single session of functional magnetic resonance imaging (fMRI)-based neurofeedback (approximately 1 hour). The investigators will assess their ability to regulate motivational networks of the brain during the exposure to alcohol cues and evaluate immediate effects on craving and cognitive bias for alcohol by administering a questionnaire and a Stroop task before and after the session.

Interventions

OTHERNeurofeedback

Sponsors

European Commission
CollaboratorOTHER
Cardiff University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* History of alcohol use disorder or current alcohol consumption above 21 units (1 unit = 8g) of alcohol per week (male participants) or above 14 units of alcohol per week (female participants)

Exclusion criteria

* MRI safety

Design outcomes

Primary

MeasureTime frameDescription
Neurofeedback success (brain activation difference during neurofeedback and baseline blocks)1 dayThis measure will be based on the analysis of participants' fMRI (functional magnetic resonance imaging) data, reflecting brain activation, during exposure to alcohol cues. Neurofeedback success will be defined as significant difference between activation levels (expressed as beta weights of a linear regression model) during the regulation periods compared to baseline. The significance will be determined by a t-test.

Secondary

MeasureTime frameDescription
Drinking Urges Questionnaire as a measure of alcohol craving1 dayMeasure of alcohol craving
Alcohol Stroop task as a measure of cognitive bias1 dayMeasure of cognitive bias

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026